title: Rituximab (MabThera) therapy and safety management. Clinical tool guide.
authors: Thao
authors: T
authors: Pham
authors: Bruno
authors: B
authors: Fautrel
authors: Jacques-Eric
authors: JE
authors: Gottenberg
authors: Philippe
authors: P
authors: Goupille
authors: Eric
authors: E
authors: Hachulla
authors: Charles
authors: C
authors: Masson
authors: Jacques
authors: J
authors: Morel
authors: Luc
authors: L
authors: Mouthon
authors: Alain
authors: A
authors: Saraux
authors: Thierry
authors: T
authors: Schaeverbeke
authors: Daniel
authors: D
authors: Wendling
authors: Xavier
authors: X
authors: Mariette
authors: Sibilia
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D064420:Drug-Related Side Effects and Adverse Reactions / Q000139:chemically induced; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D011247:Pregnancy; D011364:Professional Practice; D012219:Rheumatology / Q000379:methods*; D000069283:Rituximab; D017751:Safety Management; D014657:Vasculitis / Q000188:drug therapy
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab